These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17658958)

  • 1. Community pharmacy-based hypertension disease-management program in a Latino/Hispanic-American population.
    Lai LL
    Consult Pharm; 2007 May; 22(5):411-6. PubMed ID: 17658958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study).
    Zillich AJ; Sutherland JM; Kumbera PA; Carter BL
    J Gen Intern Med; 2005 Dec; 20(12):1091-6. PubMed ID: 16423096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustainability of Blood Pressure Reduction in Black Barbershops.
    Victor RG; Blyler CA; Li N; Lynch K; Moy NB; Rashid M; Chang LC; Handler J; Brettler J; Rader F; Elashoff RM
    Circulation; 2019 Jan; 139(1):10-19. PubMed ID: 30592662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of community pharmacy services: A systematic review and meta-analysis.
    Yuan C; Ding Y; Zhou K; Huang Y; Xi X
    Health Soc Care Community; 2019 Sep; 27(5):e567-e587. PubMed ID: 31225940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacy--ideal location to screen and monitor hypertensive patients.
    Negru DS; Diaconescu M; Petculescu AM; Bild V
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):904-9. PubMed ID: 21235128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.
    Bunting BA; Smith BH; Sutherland SE
    J Am Pharm Assoc (2003); 2008; 48(1):23-31. PubMed ID: 18192127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial.
    Svarstad BL; Kotchen JM; Shireman TI; Brown RL; Crawford SY; Mount JK; Palmer PA; Vivian EM; Wilson DA
    J Am Pharm Assoc (2003); 2013; 53(5):520-9. PubMed ID: 24030130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management.
    Machado M; Bajcar J; Guzzo GC; Einarson TR
    Ann Pharmacother; 2007 Nov; 41(11):1770-81. PubMed ID: 17925496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pharmaceutical care programme on blood pressure and quality of life in a Nigerian pharmacy.
    Aguwa CN; Ukwe CV; Ekwunife OI
    Pharm World Sci; 2008 Jan; 30(1):107-10. PubMed ID: 17703369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacy outreach services on blood pressure management in the elderly community of Hong Kong.
    Lee VW; Yi PT; Kong KW; Chan PK; Kwok FL
    Geriatr Gerontol Int; 2013 Jan; 13(1):175-81. PubMed ID: 22680786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients.
    Shireman TI; Svarstad BL
    J Am Pharm Assoc (2003); 2016; 56(4):389-96. PubMed ID: 27184784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.
    Sookaneknun P; Richards RM; Sanguansermsri J; Teerasut C
    Ann Pharmacother; 2004 Dec; 38(12):2023-8. PubMed ID: 15522983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in the effect of a telephone-delivered hypertension disease management program.
    Jackson GL; Oddone EZ; Olsen MK; Powers BJ; Grubber JM; McCant F; Bosworth HB
    J Gen Intern Med; 2012 Dec; 27(12):1682-9. PubMed ID: 22865016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of wellness coaching and monitoring services provided in a community pharmacy.
    DiDonato KL; May JR; Lindsey CC
    J Am Pharm Assoc (2003); 2013; 53(1):14-21. PubMed ID: 23636151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized Hypertension Management Using Patient-Generated Health Data Integrated With Electronic Health Records (EMPOWER-H): Six-Month Pre-Post Study.
    Lv N; Xiao L; Simmons ML; Rosas LG; Chan A; Entwistle M
    J Med Internet Res; 2017 Sep; 19(9):e311. PubMed ID: 28928111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice.
    Robinson JD; Segal R; Lopez LM; Doty RE
    Ann Pharmacother; 2010 Jan; 44(1):88-96. PubMed ID: 20040704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
    Bradley CL; Luder HR; Beck AF; Bowen R; Heaton PC; Kahn RS; Mansour M; Obszarski S; Frede SM
    J Am Pharm Assoc (2003); 2016; 56(4):455-60. PubMed ID: 27245855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study.
    Sabater-Hernández D; Sánchez-Villegas P; García-Corpas JP; Amariles P; Sendra-Lillo J; Faus MJ
    Int J Clin Pharm; 2011 Jun; 33(3):582-9. PubMed ID: 21523351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist intervention program for control of hypertension.
    Chabot I; Moisan J; Grégoire JP; Milot A
    Ann Pharmacother; 2003 Sep; 37(9):1186-93. PubMed ID: 12921497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertensive disease management community outreach program in Hispanics.
    Lai LL; Novoa G
    South Med J; 2005 Jul; 98(7):748-9. PubMed ID: 16108249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.